Forian Inc. (NASDAQ: FORA) Stock Competitors & Peer Comparison

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, GEHC has a market cap of 32.4B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while GEHC trades at $71.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas GEHC's P/E ratio is 15.74. In terms of profitability, FORA's ROE is -0.17%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, FORA is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for FORA.Check GEHC's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while GEHCV trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas GEHCV's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, FORA is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for FORA.Check GEHCV's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, BTSG has a market cap of 12.3B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while BTSG trades at $62.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas BTSG's P/E ratio is 50.35. In terms of profitability, FORA's ROE is -0.17%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, FORA is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for FORA.Check BTSG's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, TEM has a market cap of 9.1B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while TEM trades at $52.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas TEM's P/E ratio is -104.10. In terms of profitability, FORA's ROE is -0.17%, compared to TEM's ROE of -0.55%. Regarding short-term risk, FORA is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for FORA.Check TEM's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while SGFY trades at $30.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas SGFY's P/E ratio is 70.91. In terms of profitability, FORA's ROE is -0.17%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, FORA is less volatile compared to SGFY. This indicates lower risk in terms of short-term price fluctuations for FORA.Check SGFY's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, HQY has a market cap of 8.7B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while HQY trades at $104.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas HQY's P/E ratio is 24.45. In terms of profitability, FORA's ROE is -0.17%, compared to HQY's ROE of +0.11%. Regarding short-term risk, FORA is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for FORA.Check HQY's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, HNGE has a market cap of 6.9B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while HNGE trades at $89.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas HNGE's P/E ratio is 47.81. In terms of profitability, FORA's ROE is -0.17%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, FORA is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for FORA.Check HNGE's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, TXG has a market cap of 6.6B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while TXG trades at $52.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas TXG's P/E ratio is -306.06. In terms of profitability, FORA's ROE is -0.17%, compared to TXG's ROE of -0.09%. Regarding short-term risk, FORA is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for FORA.Check TXG's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while RCM trades at $14.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas RCM's P/E ratio is -102.21. In terms of profitability, FORA's ROE is -0.17%, compared to RCM's ROE of +0.00%. Regarding short-term risk, FORA is similarly volatile compared to RCM. This indicates similar risk in terms of short-term price fluctuations for FORA.Check RCM's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, DOCS has a market cap of 5.1B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while DOCS trades at $27.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas DOCS's P/E ratio is 17.91. In terms of profitability, FORA's ROE is -0.17%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, FORA is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for FORA.Check DOCS's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, WAY has a market cap of 4.6B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while WAY trades at $24.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas WAY's P/E ratio is 16.05. In terms of profitability, FORA's ROE is -0.17%, compared to WAY's ROE of +0.04%. Regarding short-term risk, FORA is less volatile compared to WAY. This indicates lower risk in terms of short-term price fluctuations for FORA.Check WAY's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while ONEM trades at $16.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas ONEM's P/E ratio is -7.77. In terms of profitability, FORA's ROE is -0.17%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, FORA is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for FORA.Check ONEM's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, PRVA has a market cap of 2.8B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while PRVA trades at $22.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas PRVA's P/E ratio is 106.90. In terms of profitability, FORA's ROE is -0.17%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, FORA is less volatile compared to PRVA. This indicates lower risk in terms of short-term price fluctuations for FORA.Check PRVA's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, HTFL has a market cap of 2.5B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while HTFL trades at $28.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas HTFL's P/E ratio is -14.34. In terms of profitability, FORA's ROE is -0.17%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, FORA is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for FORA.Check HTFL's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, WGS has a market cap of 2.3B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while WGS trades at $77.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas WGS's P/E ratio is 214.11. In terms of profitability, FORA's ROE is -0.17%, compared to WGS's ROE of -0.39%. Regarding short-term risk, FORA is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for FORA.Check WGS's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, PGNY has a market cap of 2.2B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while PGNY trades at $28.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas PGNY's P/E ratio is 20.36. In terms of profitability, FORA's ROE is -0.17%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, FORA is less volatile compared to PGNY. This indicates lower risk in terms of short-term price fluctuations for FORA.Check PGNY's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, WGSWW has a market cap of 1.8B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while WGSWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas WGSWW's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, FORA is similarly volatile compared to WGSWW. This indicates similar risk in terms of short-term price fluctuations for FORA.Check WGSWW's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while NXGN trades at $23.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas NXGN's P/E ratio is -266.00. In terms of profitability, FORA's ROE is -0.17%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, FORA is less volatile compared to NXGN. This indicates lower risk in terms of short-term price fluctuations for FORA.Check NXGN's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while OMDA trades at $23.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas OMDA's P/E ratio is 338.14. In terms of profitability, FORA's ROE is -0.17%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, FORA is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for FORA.Check OMDA's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while AGTI trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas AGTI's P/E ratio is -71.79. In terms of profitability, FORA's ROE is -0.17%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, FORA is less volatile compared to AGTI. This indicates lower risk in terms of short-term price fluctuations for FORA.Check AGTI's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, TDOC has a market cap of 1.3B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while TDOC trades at $7.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas TDOC's P/E ratio is -7.92. In terms of profitability, FORA's ROE is -0.17%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, FORA is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for FORA.Check TDOC's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while CERT trades at $8.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas CERT's P/E ratio is 20.50. In terms of profitability, FORA's ROE is -0.17%, compared to CERT's ROE of -0.07%. Regarding short-term risk, FORA is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for FORA.Check CERT's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, GDRX has a market cap of 1.3B. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while GDRX trades at $3.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas GDRX's P/E ratio is 11.50. In terms of profitability, FORA's ROE is -0.17%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, FORA is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for FORA.Check GDRX's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while CCLDO trades at $27.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas CCLDO's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, FORA is similarly volatile compared to CCLDO. This indicates similar risk in terms of short-term price fluctuations for FORA.Check CCLDO's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, HSTM has a market cap of 839.1M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while HSTM trades at $28.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas HSTM's P/E ratio is 35.46. In terms of profitability, FORA's ROE is -0.17%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, FORA is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for FORA.Check HSTM's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, PHR has a market cap of 773M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while PHR trades at $12.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas PHR's P/E ratio is 44.66. In terms of profitability, FORA's ROE is -0.17%, compared to PHR's ROE of +0.03%. Regarding short-term risk, FORA is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for FORA.Check PHR's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while MPLN-WT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, FORA is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for FORA.Check MPLN-WT's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while ACCD trades at $7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas ACCD's P/E ratio is -3.08. In terms of profitability, FORA's ROE is -0.17%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, FORA is similarly volatile compared to ACCD. This indicates similar risk in terms of short-term price fluctuations for FORA.Check ACCD's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, CTEV has a market cap of 546.7M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while CTEV trades at $32.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas CTEV's P/E ratio is -2.46. In terms of profitability, FORA's ROE is -0.17%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, FORA is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for FORA.Check CTEV's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, SOPH has a market cap of 537.5M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while SOPH trades at $7.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas SOPH's P/E ratio is -6.95. In terms of profitability, FORA's ROE is -0.17%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, FORA is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for FORA.Check SOPH's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while SHCR trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas SHCR's P/E ratio is -3.76. In terms of profitability, FORA's ROE is -0.17%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, FORA is less volatile compared to SHCR. This indicates lower risk in terms of short-term price fluctuations for FORA.Check SHCR's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, NRC has a market cap of 458.4M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while NRC trades at $20.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas NRC's P/E ratio is 24.80. In terms of profitability, FORA's ROE is -0.17%, compared to NRC's ROE of +0.48%. Regarding short-term risk, FORA is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for FORA.Check NRC's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, EVH has a market cap of 446M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while EVH trades at $3.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas EVH's P/E ratio is 30.50. In terms of profitability, FORA's ROE is -0.17%, compared to EVH's ROE of -0.99%. Regarding short-term risk, FORA is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for FORA.Check EVH's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while SLGC trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas SLGC's P/E ratio is -3.04. In terms of profitability, FORA's ROE is -0.17%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, FORA is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for FORA.Check SLGC's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while SLGCW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, FORA's ROE is -0.17%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, FORA is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for FORA.Check SLGCW's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while TBRG trades at $26.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas TBRG's P/E ratio is 9.37. In terms of profitability, FORA's ROE is -0.17%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, FORA is less volatile compared to TBRG. This indicates lower risk in terms of short-term price fluctuations for FORA.Check TBRG's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while MPLN trades at $23.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas MPLN's P/E ratio is -0.23. In terms of profitability, FORA's ROE is -0.17%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, FORA is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for FORA.Check MPLN's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, SY has a market cap of 286M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while SY trades at $2.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas SY's P/E ratio is -6.61. In terms of profitability, FORA's ROE is -0.17%, compared to SY's ROE of -0.16%. Regarding short-term risk, FORA is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for FORA.Check SY's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while TRHC trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas TRHC's P/E ratio is -4.27. In terms of profitability, FORA's ROE is -0.17%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, FORA is less volatile compared to TRHC. This indicates lower risk in terms of short-term price fluctuations for FORA.Check TRHC's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while SMFR trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas SMFR's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, FORA is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for FORA.Check SMFR's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, SPOK has a market cap of 240.6M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while SPOK trades at $11.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas SPOK's P/E ratio is 19.20. In terms of profitability, FORA's ROE is -0.17%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, FORA is less volatile compared to SPOK. This indicates lower risk in terms of short-term price fluctuations for FORA.Check SPOK's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, AMWL has a market cap of 228.6M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while AMWL trades at $13.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas AMWL's P/E ratio is -3.04. In terms of profitability, FORA's ROE is -0.17%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, FORA is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for FORA.Check AMWL's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while CPSI trades at $9.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas CPSI's P/E ratio is -183.80. In terms of profitability, FORA's ROE is -0.17%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, FORA is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for FORA.Check CPSI's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, OPRX has a market cap of 132.9M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while OPRX trades at $7.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas OPRX's P/E ratio is 6.50. In terms of profitability, FORA's ROE is -0.17%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, FORA is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for FORA.Check OPRX's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, HCAT has a market cap of 127.8M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while HCAT trades at $1.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas HCAT's P/E ratio is 8.65. In terms of profitability, FORA's ROE is -0.17%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, FORA is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for FORA.Check HCAT's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while AUGX trades at $2.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas AUGX's P/E ratio is -4.99. In terms of profitability, FORA's ROE is -0.17%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, FORA is less volatile compared to AUGX. This indicates lower risk in terms of short-term price fluctuations for FORA.Check AUGX's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, CCLD has a market cap of 111.8M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while CCLD trades at $2.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas CCLD's P/E ratio is 10.12. In terms of profitability, FORA's ROE is -0.17%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, FORA is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for FORA.Check CCLD's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, DH has a market cap of 75.3M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while DH trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas DH's P/E ratio is 2.74. In terms of profitability, FORA's ROE is -0.17%, compared to DH's ROE of -0.67%. Regarding short-term risk, FORA is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for FORA.Check DH's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, WORX has a market cap of 72.8M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while WORX trades at $4.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas WORX's P/E ratio is -5.29. In terms of profitability, FORA's ROE is -0.17%, compared to WORX's ROE of -0.65%. Regarding short-term risk, FORA is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for FORA.Check WORX's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while CCLDP trades at $19.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas CCLDP's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, FORA is less volatile compared to CCLDP. This indicates lower risk in terms of short-term price fluctuations for FORA.Check CCLDP's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, ONMDW has a market cap of 37M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while ONMDW trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas ONMDW's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, FORA is similarly volatile compared to ONMDW. This indicates similar risk in terms of short-term price fluctuations for FORA.Check ONMDW's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, ONMD has a market cap of 35.6M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while ONMD trades at $0.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas ONMD's P/E ratio is -4.16. In terms of profitability, FORA's ROE is -0.17%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, FORA is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for FORA.Check ONMD's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while SNCE trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas SNCE's P/E ratio is -0.27. In terms of profitability, FORA's ROE is -0.17%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, FORA is less volatile compared to SNCE. This indicates lower risk in terms of short-term price fluctuations for FORA.Check SNCE's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while AKLI trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas AKLI's P/E ratio is -0.71. In terms of profitability, FORA's ROE is -0.17%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, FORA is less volatile compared to AKLI. This indicates lower risk in terms of short-term price fluctuations for FORA.Check AKLI's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while SHLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas SHLT's P/E ratio is -3.87. In terms of profitability, FORA's ROE is -0.17%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, FORA is similarly volatile compared to SHLT. This indicates similar risk in terms of short-term price fluctuations for FORA.Check SHLT's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while SHCRW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, FORA's ROE is -0.17%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, FORA is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for FORA.Check SHCRW's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while STRM trades at $5.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas STRM's P/E ratio is -2.40. In terms of profitability, FORA's ROE is -0.17%, compared to STRM's ROE of -0.65%. Regarding short-term risk, FORA is similarly volatile compared to STRM. This indicates similar risk in terms of short-term price fluctuations for FORA.Check STRM's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while RNLX trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas RNLX's P/E ratio is -0.33. In terms of profitability, FORA's ROE is -0.17%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, FORA is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for FORA.Check RNLX's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while LIFW trades at $3.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas LIFW's P/E ratio is -0.02. In terms of profitability, FORA's ROE is -0.17%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, FORA is similarly volatile compared to LIFW. This indicates similar risk in terms of short-term price fluctuations for FORA.Check LIFW's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while BBLN trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas BBLN's P/E ratio is -0.04. In terms of profitability, FORA's ROE is -0.17%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, FORA is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for FORA.Check BBLN's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, BEATW has a market cap of 11.7M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while BEATW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas BEATW's P/E ratio is -0.03. In terms of profitability, FORA's ROE is -0.17%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, FORA is similarly volatile compared to BEATW. This indicates similar risk in terms of short-term price fluctuations for FORA.Check BEATW's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while ETAO trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas ETAO's P/E ratio is -0.01. In terms of profitability, FORA's ROE is -0.17%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, FORA is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for FORA.Check ETAO's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, MGRX has a market cap of 8.3M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while MGRX trades at $0.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas MGRX's P/E ratio is -0.36. In terms of profitability, FORA's ROE is -0.17%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, FORA is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for FORA.Check MGRX's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, BFRG has a market cap of 6.9M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while BFRG trades at $0.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas BFRG's P/E ratio is -1.09. In terms of profitability, FORA's ROE is -0.17%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, FORA is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for FORA.Check BFRG's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, SCNX has a market cap of 5.9M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while SCNX trades at $0.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas SCNX's P/E ratio is -0.15. In terms of profitability, FORA's ROE is -0.17%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, FORA is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for FORA.Check SCNX's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while UPH trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas UPH's P/E ratio is -0.07. In terms of profitability, FORA's ROE is -0.17%, compared to UPH's ROE of -1.05%. Regarding short-term risk, FORA is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for FORA.Check UPH's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while UPH-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, FORA is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for FORA.Check UPH-WT's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while PEAR trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas PEAR's P/E ratio is -0.08. In terms of profitability, FORA's ROE is -0.17%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, FORA is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for FORA.Check PEAR's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while PEARW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas PEARW's P/E ratio is -0.00. In terms of profitability, FORA's ROE is -0.17%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, FORA is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for FORA.Check PEARW's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while OTRK trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas OTRK's P/E ratio is -0.02. In terms of profitability, FORA's ROE is -0.17%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, FORA is similarly volatile compared to OTRK. This indicates similar risk in terms of short-term price fluctuations for FORA.Check OTRK's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while CMAX trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas CMAX's P/E ratio is -0.00. In terms of profitability, FORA's ROE is -0.17%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, FORA is similarly volatile compared to CMAX. This indicates similar risk in terms of short-term price fluctuations for FORA.Check CMAX's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, HCTI has a market cap of 1.4M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while HCTI trades at $1.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas HCTI's P/E ratio is -0.16. In terms of profitability, FORA's ROE is -0.17%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, FORA is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for FORA.Check HCTI's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, VSEEW has a market cap of 1.4M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while VSEEW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, FORA's ROE is -0.17%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, FORA is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for FORA.Check VSEEW's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while LIFWZ trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, FORA is similarly volatile compared to LIFWZ. This indicates similar risk in terms of short-term price fluctuations for FORA.Check LIFWZ's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, ACON has a market cap of 1.2M. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while ACON trades at $2.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas ACON's P/E ratio is -0.25. In terms of profitability, FORA's ROE is -0.17%, compared to ACON's ROE of -0.59%. Regarding short-term risk, FORA is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for FORA.Check ACON's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, EUDAW has a market cap of 952.7K. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while EUDAW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, FORA's ROE is -0.17%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, FORA is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for FORA.Check EUDAW's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, VSEE has a market cap of 816.5K. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while VSEE trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas VSEE's P/E ratio is -0.10. In terms of profitability, FORA's ROE is -0.17%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, FORA is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for FORA.Check VSEE's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while MSPRZ trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, FORA is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for FORA.Check MSPRZ's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while KERN trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas KERN's P/E ratio is -0.01. In terms of profitability, FORA's ROE is -0.17%, compared to KERN's ROE of -0.20%. Regarding short-term risk, FORA is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for FORA.Check KERN's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while KERNW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas KERNW's P/E ratio is -0.00. In terms of profitability, FORA's ROE is -0.17%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, FORA is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for FORA.Check KERNW's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while LIFWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas LIFWW's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, FORA is similarly volatile compared to LIFWW. This indicates similar risk in terms of short-term price fluctuations for FORA.Check LIFWW's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, ZCMD has a market cap of 37.5K. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while ZCMD trades at $1.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas ZCMD's P/E ratio is -0.04. In terms of profitability, FORA's ROE is -0.17%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, FORA is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for FORA.Check ZCMD's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while CMAXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas CMAXW's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, FORA is similarly volatile compared to CMAXW. This indicates similar risk in terms of short-term price fluctuations for FORA.Check CMAXW's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, ACONW has a market cap of 13.2K. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while ACONW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas ACONW's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, FORA is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for FORA.Check ACONW's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while KURIU trades at $9.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas KURIU's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, FORA is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for FORA.Check KURIU's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while CNVY trades at $10.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas CNVY's P/E ratio is -71.50. In terms of profitability, FORA's ROE is -0.17%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, FORA is less volatile compared to CNVY. This indicates lower risk in terms of short-term price fluctuations for FORA.Check CNVY's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, NH has a market cap of 0. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while NH trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas NH's P/E ratio is -0.12. In terms of profitability, FORA's ROE is -0.17%, compared to NH's ROE of +0.35%. Regarding short-term risk, FORA is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for FORA.Check NH's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while MTBCP trades at $26.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas MTBCP's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, FORA is less volatile compared to MTBCP. This indicates lower risk in terms of short-term price fluctuations for FORA.Check MTBCP's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while SMFRW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas SMFRW's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, FORA is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for FORA.Check SMFRW's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while MSPRV trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas MSPRV's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to MSPRV's ROE of N/A. Regarding short-term risk, FORA is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for FORA.Check MSPRV's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, IMS has a market cap of 0. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while IMS trades at $31.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas IMS's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to IMS's ROE of +0.27%. Regarding short-term risk, FORA is less volatile compared to IMS. This indicates lower risk in terms of short-term price fluctuations for FORA.Check IMS's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while NAVA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas NAVA's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, FORA is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for FORA.Check NAVA's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while AFFX trades at $14.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas AFFX's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, FORA is less volatile compared to AFFX. This indicates lower risk in terms of short-term price fluctuations for FORA.Check AFFX's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while MTBC trades at $3.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas MTBC's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, FORA is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for FORA.Check MTBC's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while CSLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas CSLT's P/E ratio is -37.27. In terms of profitability, FORA's ROE is -0.17%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, FORA is less volatile compared to CSLT. This indicates lower risk in terms of short-term price fluctuations for FORA.Check CSLT's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while CHNG trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas CHNG's P/E ratio is -152.72. In terms of profitability, FORA's ROE is -0.17%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, FORA is less volatile compared to CHNG. This indicates lower risk in terms of short-term price fluctuations for FORA.Check CHNG's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while CHNGU trades at $73.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas CHNGU's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, FORA is less volatile compared to CHNGU. This indicates lower risk in terms of short-term price fluctuations for FORA.Check CHNGU's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while MTBCO trades at $25.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas MTBCO's P/E ratio is N/A. In terms of profitability, FORA's ROE is -0.17%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, FORA is less volatile compared to MTBCO. This indicates lower risk in terms of short-term price fluctuations for FORA.Check MTBCO's competition here

Forian Inc. (NASDAQ: FORA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FORA stands at 67.8M. In comparison, CERN has a market cap of 0. Regarding current trading prices, FORA is priced at $2.17 on the NASDAQ, while CERN trades at $94.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FORA currently has a P/E ratio of -24.11, whereas CERN's P/E ratio is 55.84. In terms of profitability, FORA's ROE is -0.17%, compared to CERN's ROE of +0.14%. Regarding short-term risk, FORA is less volatile compared to CERN. This indicates lower risk in terms of short-term price fluctuations for FORA.Check CERN's competition here